New York State Common Retirement Fund Acadia Pharmaceuticals Inc Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 51,374 shares of ACAD stock, worth $958,638. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,374
Previous 45,064
14.0%
Holding current value
$958,638
Previous $693,000
36.08%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding ACAD
# of Institutions
282Shares Held
158MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$800 Million7.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.8MShares$258 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$256 Million3.36% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$225 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$111 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.02B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...